Global Drug of Abuse (DOA) Testing Equipment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Drug of Abuse (DOA) Testing Equipment

• 1.1 Definition of Drug of Abuse (DOA) Testing Equipment
• 1.2 Drug of Abuse (DOA) Testing Equipment Segment by Type
  • 1.2.1 Global Drug of Abuse (DOA) Testing Equipment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Immunoassay analyzers
  • 1.2.3 Chromatography instruments
  • 1.2.4 Breath analyzers
  • 1.2.5 Others
• 1.3 Drug of Abuse (DOA) Testing Equipment Segment by Applications
  • 1.3.1 Global Drug of Abuse (DOA) Testing Equipment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Laboratories
  • 1.3.4 Workplace
  • 1.3.5 At-Home
• 1.4 Global Drug of Abuse (DOA) Testing Equipment Overall Market
  • 1.4.1 Global Drug of Abuse (DOA) Testing Equipment Revenue (2014-2025)
  • 1.4.2 Global Drug of Abuse (DOA) Testing Equipment Production (2014-2025)
  • 1.4.3 North America Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)
  • 1.4.4 Europe Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)
  • 1.4.5 China Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)
  • 1.4.6 Japan Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)
  • 1.4.8 India Drug of Abuse (DOA) Testing Equipment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing Equipment
• 2.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Equipment
• 2.4 Industry Chain Structure of Drug of Abuse (DOA) Testing Equipment

3 Development and Manufacturing Plants Analysis of Drug of Abuse (DOA) Testing Equipment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Drug of Abuse (DOA) Testing Equipment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Drug of Abuse (DOA) Testing Equipment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Drug of Abuse (DOA) Testing Equipment Production and Capacity Analysis
• 4.2 Drug of Abuse (DOA) Testing Equipment Revenue Analysis
• 4.3 Drug of Abuse (DOA) Testing Equipment Price Analysis
• 4.4 Market Concentration Degree

5 Drug of Abuse (DOA) Testing Equipment Regional Market Analysis

• 5.1 Drug of Abuse (DOA) Testing Equipment Production by Regions
  • 5.1.1 Global Drug of Abuse (DOA) Testing Equipment Production by Regions
  • 5.1.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Regions
• 5.2 Drug of Abuse (DOA) Testing Equipment Consumption by Regions
• 5.3 North America Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.3.1 North America Drug of Abuse (DOA) Testing Equipment Production
  • 5.3.2 North America Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Drug of Abuse (DOA) Testing Equipment Import and Export
• 5.4 Europe Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.4.1 Europe Drug of Abuse (DOA) Testing Equipment Production
  • 5.4.2 Europe Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Drug of Abuse (DOA) Testing Equipment Import and Export
• 5.5 China Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.5.1 China Drug of Abuse (DOA) Testing Equipment Production
  • 5.5.2 China Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Drug of Abuse (DOA) Testing Equipment Import and Export
• 5.6 Japan Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.6.1 Japan Drug of Abuse (DOA) Testing Equipment Production
  • 5.6.2 Japan Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Drug of Abuse (DOA) Testing Equipment Import and Export
• 5.7 Southeast Asia Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.7.1 Southeast Asia Drug of Abuse (DOA) Testing Equipment Production
  • 5.7.2 Southeast Asia Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Drug of Abuse (DOA) Testing Equipment Import and Export
• 5.8 India Drug of Abuse (DOA) Testing Equipment Market Analysis
  • 5.8.1 India Drug of Abuse (DOA) Testing Equipment Production
  • 5.8.2 India Drug of Abuse (DOA) Testing Equipment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Drug of Abuse (DOA) Testing Equipment Import and Export

6 Drug of Abuse (DOA) Testing Equipment Segment Market Analysis (by Type)

• 6.1 Global Drug of Abuse (DOA) Testing Equipment Production by Type
• 6.2 Global Drug of Abuse (DOA) Testing Equipment Revenue by Type
• 6.3 Drug of Abuse (DOA) Testing Equipment Price by Type

7 Drug of Abuse (DOA) Testing Equipment Segment Market Analysis (by Application)

• 7.1 Global Drug of Abuse (DOA) Testing Equipment Consumption by Application
• 7.2 Global Drug of Abuse (DOA) Testing Equipment Consumption Market Share by Application (2014-2019)

8 Drug of Abuse (DOA) Testing Equipment Major Manufacturers Analysis

• 8.1 Siemens AG
  • 8.1.1 Siemens AG Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.1.2 Siemens AG Product Introduction, Application and Specification
  • 8.1.3 Siemens AG Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Merck
  • 8.2.1 Merck Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.2.2 Merck Product Introduction, Application and Specification
  • 8.2.3 Merck Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Roche
  • 8.3.1 Roche Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.3.2 Roche Product Introduction, Application and Specification
  • 8.3.3 Roche Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Thermo Fisher Scientific
  • 8.4.1 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.4.2 Thermo Fisher Scientific Product Introduction, Application and Specification
  • 8.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Bio-Rad
  • 8.5.1 Bio-Rad Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.5.2 Bio-Rad Product Introduction, Application and Specification
  • 8.5.3 Bio-Rad Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Abbott
  • 8.6.1 Abbott Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.6.2 Abbott Product Introduction, Application and Specification
  • 8.6.3 Abbott Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Quest Diagnostics
  • 8.7.1 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.7.2 Quest Diagnostics Product Introduction, Application and Specification
  • 8.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Express Diagnostics Int'l
  • 8.8.1 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.8.2 Express Diagnostics Int'l Product Introduction, Application and Specification
  • 8.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Psychemedics
  • 8.9.1 Psychemedics Drug of Abuse (DOA) Testing Equipment Production Sites and Area Served
  • 8.9.2 Psychemedics Product Introduction, Application and Specification
  • 8.9.3 Psychemedics Drug of Abuse (DOA) Testing Equipment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Drug of Abuse (DOA) Testing Equipment Market

• 9.1 Global Drug of Abuse (DOA) Testing Equipment Market Trend Analysis
  • 9.1.1 Global Drug of Abuse (DOA) Testing Equipment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Drug of Abuse (DOA) Testing Equipment Regional Market Trend
  • 9.2.1 North America Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
  • 9.2.2 Europe Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
  • 9.2.3 China Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
  • 9.2.4 Japan Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
  • 9.2.5 Southeast Asia Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
  • 9.2.6 India Drug of Abuse (DOA) Testing Equipment Forecast 2019-2025
• 9.3 Drug of Abuse (DOA) Testing Equipment Market Trend (Product Type)
• 9.4 Drug of Abuse (DOA) Testing Equipment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Drug of Abuse (DOA) Testing Equipment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List